Rating Change
Raymond James analysts initiated coverage on MapLight Therapeutics, Inc. (NASDAQ:MPLT) with a Strong Buy rating on June 25, 2026.
Rating Change Raymond James analysts initiated coverage on MapLight Therapeutics, Inc. (NASDAQ:MPLT) with a Strong Buy rating on June 25, 2026. Market Context MapLight…

Raymond James analysts initiated coverage on MapLight Therapeutics, Inc. (NASDAQ:MPLT) with a Strong Buy rating on June 25, 2026.
MapLight Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $30.65 with a market capitalization of $15.9M.
Analyst coverage from Raymond James provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for MapLight Therapeutics, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jun 25, 2026 | Raymond James | Strong Buy | N/A |
| Jun 23, 2026 | Craig-Hallum | Buy | N/A |
| Jun 22, 2026 | Needham | Buy | N/A |
| Jun 02, 2026 | Stifel | Buy | N/A |
| May 28, 2026 | HC Wainwright & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View MPLT Stock Page
A Strong Buy rating from Raymond James reflects the analyst's outlook on MapLight Therapeutics, Inc. (NASDAQ:MPLT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the MPLT forecast page.
Current market data
NASDAQ · MPLT
$11.95
Up: +$0.57 · +5.01%
Live quote updated
Keep reading
sec_filing ·
analyst ·
analyst ·
analyst ·